Navigation Links
DURECT Corporation Announces First Quarter 2011 Financial Results and Update of Programs
Date:5/5/2011

ely 300 patients, in the third quarter of 2011 with top-line data anticipated in the fourth quarter of 2011.  Based on a pooled and blinded analysis of the variability of data within BESST, we do not plan to increase the size of the study.

In February 2011, we announced results from a shoulder surgery Phase II study conducted in Europe by Nycomed.
At that time, we and Nycomed amended our agreement such that, for an interim period, DURECT will have full control and financial responsibility for non-clinical and CMC activities which had been previously jointly controlled and funded by DURECT and Nycomed.  If Nycomed elects to continue European development of POSIDUR after evaluation of BESST data, under the terms of the amendment, DURECT and Nycomed would resume joint control and financial responsibility of the non-clinical and CMC activities for the E.U. and the U.S.

POSIDUR is our post-operative pain relief depot that utilizes our patented SABER technology to deliver bupivacaine to provide up to three days of pain relief after surgery. POSIDUR is licensed to Hospira for commercialization in the U.S. and Canada, and to Nycomed for commercialization in Europe and other defined countries. We have retained commercialization rights in Japan and all other countries not subject to the Nycomed and Hospira licenses.

  • ELADUR (TRANSDUR®-Bupivacaine).  Pfizer completed its acquisition of King in February 2011 and as a result has assumed the development and commercialization rights and obligations to ELADUR.  In April 2011, we announced top-line results from a Phase II clinical trial conducted by King for the treatment of chronic low back pain.  The primary efficacy endpoint for the trial was not met.  Complete data analysis is on-going.  We and Pfizer are continuing to analyze these data and will work together to determine next steps for ELADUR.

  • ELADUR is our proprietary transdermal patc
    '/>"/>

    SOURCE DURECT Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related biology technology :

    1. DURECT Corporation Announces Fourth Quarter and Year End 2010 Financial Results
    2. DURECT Corporation Invites You to Join its Third Quarter 2010 Earnings Conference Call
    3. DURECT Corporation Announces Third Quarter 2008 Financial Results
    4. DURECTs Collaboration With Alpharma Clears HSR Review and Is Effective
    5. Techne Corporation Declares Dividend
    6. Techne Corporation Announces Acquisition
    7. SynapDx Corporation Licenses Autism Diagnostic Discoveries From Childrens Hospital Boston
    8. Vestaron Corporation Announces New Leadership
    9. Mitsubishi Chemical Corporation Signs Memorandum of Understanding for Strategic Partnership With Genomatica for Sustainable Chemicals in Asia
    10. Every Day is Earth Day for Yulex Corporation
    11. Veteran Wall Street Securities Analyst Reports on Health Discovery Corporation
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/22/2014)... (TSXV: BRM) ("Biorem" or "the Company") today announced results for the three ... second quarter financial statements and MD&A have been filed on SEDAR ( ... Six-months ended June 30, ( in CDN$,000 except per share ... 2014 , 2013 Revenue , 2,459 , ... 56 , 1,485 , 385 , ...
    (Date:8/22/2014)... University of Surrey have discovered how the receptors responsible ... genes. , The new study, published today in ... activity in turn regulates the cycle of all cells ... that the local biological clock and its control are ... clock in bladder physiology and ageing. , ...
    (Date:8/22/2014)... (August 22nd), in the scientific journal PLoS ... establish the effect of serotonin on sensitivity to ... optical techniques., "Serotonin is a small molecule known ... brain functions, from the control of sleep and ... This neurotransmitter is also popularly thought to contribute ...
    (Date:8/22/2014)... The first direct observations of how facets form ... towards more sophisticated and effective nanocrystal design and ... describing crystal growth breaks down at the nanoscale. ... (DOE),s Lawrence Berkeley National Laboratory (Berkeley Lab) used ... high-resolution, fast-detection camera to capture the physical ...
    Breaking Biology Technology:Biorem Reports 2014 Second Quarter Results 2Biorem Reports 2014 Second Quarter Results 3Treatment for overactive bladder and irritable bowel syndrome advanced through pioneering research 2From happiness to pain: Understanding serotonin's function 2Shaping the future of nanocrystals 2Shaping the future of nanocrystals 3Shaping the future of nanocrystals 4
    ... an award-winning remote-detection version of NMR/MRI technology with ... microfluidic chips, researchers with the U.S. Department of ... have opened the door to a portable system ... be impractical if not impossible with conventional technologies. ...
    ... Around the globe, many nations are realizing that the ... say. And because an intentional introduction of bacteria, ... World Organization for Animal Health is issuing a paper ... beginning to think about maintaining international trade needs to ...
    ... of careful theoretical modeling and precise micro-manufacturing, a team ... of ultra-thin, self-adhesive electronics device that can effectively measure ... activity all without the use of bulky equipment, ... a new class of micro-electronics with a technology that ...
    Cached Biology Technology:Berkeley Lab researchers apply NMR/MRI to microfluidic chromatography 2Berkeley Lab researchers apply NMR/MRI to microfluidic chromatography 3Berkeley Lab researchers apply NMR/MRI to microfluidic chromatography 4Global bioterrorism threat analyzed for world animal health office 2Stick-on tattoos go electric 2Stick-on tattoos go electric 3
    (Date:8/22/2014)... Calif. Thomson Reuters , a leading source ... researchers at the University of California, Riverside in its ... minds of our times." , To generate the list, ... to identify researchers whose published work has had enormous ... among some 3,200 individuals who published the greatest number ...
    (Date:8/22/2014)... Research presented at the 29th Annual International ... by Hera Therapeutics Inc. combats three types of ... percent of all cervical cancer. , When tested ... the replication of HPV-16, HPV-18 and HPV-11 cells, ... Broker, Ph.D., who presented the findings at the ...
    (Date:8/22/2014)... is available in French . ... essential nutrients from African soils looming as a major threat ... today finds that over the last five years, 1.7 million ... have rejuvenated 1.6 million hectares and helped them double or ... for a Green Revolution in Africa (AGRA) focuses on intensive ...
    Breaking Biology News(10 mins):5 UC Riverside scientists among world's most influential scientific minds 2Effort to confront Africa's soil health crisis helps millions of farmers triple yields 2Effort to confront Africa's soil health crisis helps millions of farmers triple yields 3Effort to confront Africa's soil health crisis helps millions of farmers triple yields 4
    ... mammalian embryo is one of the most contentious topics ... Hiiragi have new evidence to fuel the ongoing debate. ... showed compelling evidence for the absence of predetermined polarity ... contrast to those who feel that the site of ...
    ... novel retroviral resistance gene, called FEZ1, that can mediate a ... in cell culture. The researchers found that the high level ... caused a significant block to retroviral infection ?retroviruses were able ... but were excluded from entering the host cell nucleus. , ...
    ... drug motexafin gadolinium (brand name: Xcytrin, manufactured by Pharmacyclics, ... enzymes involved in cellular metabolism, according to a team ... of biochemistry and molecular biology at the Keck School ... The cellular disruption results in increases in the amount ...
    Cached Biology News:USC researchers determine mechanism of action of chemotherapy drug 2